{
    "2021-03-01": [
        [
            {
                "time": "2023-10-18",
                "original_text": "Top Analyst Reports for Tesla, Intel & Verizon",
                "features": {
                    "keywords": [
                        "Tesla",
                        "Intel",
                        "Verizon",
                        "Analyst Reports"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "automotive",
                        "telecommunications"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "Homology Medicines Regains Global Rights To Novartis Ophthalmology Program",
                "features": {
                    "keywords": [
                        "Homology Medicines",
                        "Novartis",
                        "Ophthalmology",
                        "Global Rights"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}